Not Tagged
Not Tagged
[]
 prospect #asco23 plenary #larc elig for sphinct-sparing surg: neoadj folfox x6 + select crt (9.1% got crt for &lt;20% in tumor size on folfox) tme adj folfox x6 noninferior to lcrt tme adj chemo (5-yr dfs 80.8 vs 78.6%) w/similar os, local recur 
Medical oncologist and researcher in gastrointestinal and genitourinary cancers @CedarsSinai. Hematology/Oncology fellowship @cityofhope